Cognitive Dysfunction in Multiple Sclerosis (1)

Cognitive Dysfunction in Multiple Sclerosis

Tuesday, June 21, 2011

The New York Academy of Sciences

Presented By

Presented by The New York Academy of Sciences

 

In less than two decades remarkable advances have been made in the therapeutics of MS, particularly in the development of disease-modifying treatments for relapsing forms of the disease. From no treatment available prior to 1993, the therapeutic armamentarium has expanded to include 8 FDA-approved agents currently marketed in the US. Many other drugs and biologicals are in advanced stages of clinical development, with several having reported successful results in Phase III trials. These have novel mechanisms of action and more desirable routes or frequency of administration than the injectable drugs that have been the mainstay of MS therapy in the 1990s and the first decade of the 21st century. These advances will make the treatment of MS more effective, but also more challenging and complex as MS specialists seek to optimize treatment on an individual basis. While therapeutic activity for relapsing MS has perhaps exceeded that in all of neurology during the past two decades, nonetheless the lack of effective therapy for progressive forms of MS remains a major disappointment. This talk will highlight the currently marketed drugs, describe the new therapeutic agents nearing possible FDA approval, and review the issues that continue to confront investigators in the field.

Reception to follow.

Keynote Speaker

Aaron E. Miller, MD

Mount Sinai School of Medicine

Panelists

Jeffery N. Gingold

MS Patient Advocate

Nicholas G. LaRocca, PhD

National Multiple Sclerosis Society

Cynthia Sitcov

MS Patient Advocate

Registration Pricing

Member:$15
Student Member:$15
Nonmember:$25
Student Nonmember:$20

 

Presented by

Gold Sponsors

For a full list of sponsors, please visit the Sponsors tab.

Agenda

*Presentation times are subject to change.


5:00 PM

Registration

5:30 PM

Welcome Remarks
Sonya Dougal. PhD, The New York Academy of Sciences

5:45 PM

Keynote Address
State of the Science in Therapeutics for Multiple Scelrosis
Aaron E. Miller, MD, Mount Sinai School of Medicine

6:30 PM

Panel Discussion

- Jeffrey N. Gingold, MS Patient Advocate
- Nicholas G. LaRocca, PhD, National Multiple Sclerosis Society
- Cynthia Sitcov, MS Patient Advocate

Moderator:
Aaron E. Miller, MD, Mount Sinai School of Medicine

7:30 PM

Networking Reception

Travel & Lodging

Our Location

The New York Academy of Sciences

7 World Trade Center
250 Greenwich Street, 40th floor
New York, NY 10007-2157
212.298.8600

Click here for directions.

Hotels Near 7 World Trade Center

Recommended partner hotel:

 

The New York Academy of Sciences is a part of the Club Quarters network. Please feel free to make accommodations with Club Quarters on-line to save significantly on hotel costs.

Club Quarters Reservation Password: NYAS

Club Quarters, World Trade Center
140 Washington Street
New York, NY 10006
Phone: (212) 577-1133

Located on the south side of the World Trade Center, opposite Memorial Plaza, Club Quarters, 140 Washington Street, is just a short walk to our location.

Other hotels located near 7 WTC:

Millenium Hilton

212.693.2001

Marriott Financial Center

212.385.4900

Club Quarters, Wall Street

212.269.6400

Eurostars Wall Street Hotel

212.742.0003

Wall Street District Hotel

212.232.7700

Wall Street Inn

212.747.1500

Ritz-Carlton New York, Battery Park

212.344.0800

Special Needs and Additional Information

For any additional information and for special needs, including child/family care resources available to conference attendees, please e-mail cocampo@nyas.org or call Crystal Ocampo 212.298.8632.